The regulatory direction on compounded peptides has been toward tighter controls. If you’re told a peptide is available “through compounding”, that pathway is narrower than it used to be.
Read updateA recurring pattern across peptide sellers is the “for research use only / not for human consumption” disclaimer. It’s a liability shield for the seller, not a legal pathway for the buyer.
Read updateRegistered GLP-1 medicines like semaglutide and tirzepatide are lawful prescription products. High demand has driven a parallel market in unapproved “compounded” and online copies — a different and riskier category.
Read updateThis is general education, not medical advice. Peptides.au does not sell, supply, recommend or promote any product or clinic. Always speak with a registered Australian health practitioner before making any health decision.